Last reviewed · How we verify
VE800
At a glance
| Generic name | VE800 |
|---|---|
| Sponsor | Vedanta Biosciences, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Diarrhea
- Fatigue
- Anaemia
- Hyponatremia
- Rash
- Lymphocyte Count Decrease
- Constipation
- Hypoalbuminemia
- Pruritus
- Myalgia
- Headache
- Decreased Appetite
Key clinical trials
- Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |